Fredag 26 September | 22:33:52 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-10-10 N/A Extra Bolagsstämma 2025
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2025-03-18 - Bokslutskommuniké 2024
2025-01-14 - Split OBSRV 15:1
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-27 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 - Årsstämma
2024-03-13 - Bokslutskommuniké 2023
2023-11-22 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-11-03 - 15-10 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2022-06-03 - Årsstämma
2022-03-29 - Bokslutskommuniké 2021
2022-02-04 - Extra Bolagsstämma 2022
2021-11-03 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-25 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-23 - Bokslutskommuniké 2020
2020-11-03 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 - Årsstämma
2020-06-16 - Extra Bolagsstämma 2020
2020-05-12 - Kvartalsrapport 2020-Q1
2020-02-25 - Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamt inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2025-09-25 16:05:00

Oslo, 25 September 2025 - Observe Medical ASA (the "Company" or "Observe Medical") announces further progress in the Italian market.

The Company's distributor in Italy has secured a public tender to supply UnoMeter™ products into the largest region in Italy, corresponding to an estimated olume of approximately 240,000 units annually for a period of three years.

Following extended cooperation, Observe Medical has also entered into a mutually exclusive distribution agreement with the distributor for the UnoMeter™ product family in Italy. In addition, the Company has received a significant order related to this agreement.

Jørgen Mann, CEO of Observe Medical, commented: "Italy has historically been one of the markets where the UnoMeter™ products have held the highest market shares and by winning the largest region in Italy which represents more than 15% of the market, on top of the already gained business, secures  a strong growth for Observe Medical and a solid basis for further market share expansion".

Observe Medical reminds investors, analysts, and other stakeholders of the Company's upcoming trading update on Tuesday 7 October 2025, at 09:00 CET, which will be held virtually and streamed via webcast at the following link:  https://channel.royalcast.com/landingpage/hegnarmedia/20251007_1/

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.